CRISPR technology: The engine that drives cancer therapy
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference168 articles.
1. Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa;Zegans;J. Bacteriol.,2009
2. A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes;Haft;PLoS Comput. Biol.,2005
3. CRISPR/Cas9 gene editing: a new therapeutic approach in the treatment of infection and autoimmunity;Mohammadzadeh;IUBMB Life,2020
4. Multiplex genome engineering using CRISPR/Cas systems;Cong;Science,2013
5. Substrate generation for endonucleases of CRISPR/cas systems;Zoephel;J. Vis. Exp.,2012
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System;ACS Synthetic Biology;2024-06-11
2. Pharmacological potential of cyclic nucleotide signaling in immunity;Pharmacology & Therapeutics;2024-06
3. Genome editing: An insight into disease resistance, production efficiency, and biomedical applications in livestock;Functional & Integrative Genomics;2024-05-06
4. The intricate dance of tumor evolution: Exploring immune escape, tumor migration, drug resistance, and treatment strategies;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-04
5. Advances and applications of nanoparticles in cancer therapy;MedComm – Oncology;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3